Idiopathic Pulmonary Fibrosis

Latest News in Idiopathic Pulmonary Fibrosis

April 1, 2025

Innovative Therapy Shows Promise in Reversing Lung Scarring in Idiopathic Pulmonary Fibrosis – Arizona College of Medicine – Phoenix

March 20, 2025

Multi-Omics Delivers New Targets for Idiopathic Pulmonary Fibrosis – Inside Precision Medicine

March 13, 2025

Identification and validation of biomarkers related to ferroptosis in idiopathic pulmonary fibrosis – Nature

March 7, 2025

One in Five Idiopathic Pulmonary Fibrosis Deaths May Be Due to Occupational Exposures – HealthDay

March 3, 2025

Pliant Therapeutics Provides Update on BEACON-IPF, a Phase 2b/3 Trial in Patients with Idiopathic Pulmonary Fibrosis – GlobeNewswire

104 Active Idiopathic Pulmonary Fibrosis Clinical Trials

As of June 21, 2025

Source: clinicaltrials.gov

LOCATE

CLINICAL TRIALS

BROWSE

FDA-approved DRUGS

WHAT IS

CONGRESS DOING?